Genentech, Novartis Sued Over Asthma Drug Patent
Celltrion Healthcare has urged a London court to invalidate a patent for a drug used to treat severe asthma and chronic hives belonging to Swiss pharma giant Novartis and California-based Genentech,...To view the full article, register now.
Already a subscriber? Click here to view full article